Evidence map›Paper›PMID 39650595›Full record

ArticleImplementation research and practice

A conceptual framework for assessing implementation strategy integrity.

Todd Molfenter, Lori Ducharme, Lynda Stein, Steven Belenko, Shannon Gwin Mitchell, Dennis P Watson, Matthew C Aalsma, Peter D Friedmann, Jennifer E Becan, Bryan R Garner and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in Implementation research and practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07528846 (Justice Community Overdose Innovation Network II TCU Hub), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07528846 nanot yet recruitingnot on this map

Justice Community Overdose Innovation Network II TCU Hub: TCU Building Resilient Initiatives for Deflection Through Greater Engagement Project (TCU BRIDGE to Deflection Project)

TypeinterventionalSponsorTexas Christian UniversityRan2026 to 2029Enrolled1,620ConditionsSubstance Use Disorder (SUD), Drug Overdose, Criminal BehaviorArmsCore-interagency community engagement approach, Enhanced-Core plus community engagement specialist
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Todd MolfenterCenter for Health Enhancement System Studies (CHESS), University of Wisconsin-Madison, Madison, WI, USA.ORCID https://orcid.org/0000-0003-3033-416X
Lori DucharmeServices Research Branch, National Institute on Drug Abuse, Gaithersburg, MD, USA.
Lynda SteinDepartment of Psychology and Department of Behavioral Healthcare, College of Health Sciences, University of Rhode Island, Kingston, RI, USA.
Steven BelenkoDepartment of Criminal Justice, Temple University, Philadelphia, PA, USA.
Shannon Gwin MitchellFriends Research Institute, Baltimore, MD, USA.ORCID https://orcid.org/0000-0002-2841-1085
Dennis P WatsonChestnut Health Systems, Chicago, IL, USA.ORCID https://orcid.org/0000-0001-7208-5160
Matthew C AalsmaDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Peter D FriedmannDepartment of Medicine, Division of General Internal Medicine, Baystate Health, Springfield, MA, USA.
Jennifer E BecanCollege of Science and Engineering, Institute of Behavioral Research, Texas Christian University, Fort Worth, TX, USA.
Bryan R GarnerDepartment of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Jessica VechinskiCenter for Health Enhancement System Studies (CHESS), University of Wisconsin-Madison, Madison, WI, USA.
Alida BourisCrown Family School of Social Work, Policy and Practice, The University of Chicago, Chicago, IL, USA.
Emily ClaypoolCrown Family School of Social Work, Policy and Practice, The University of Chicago, Chicago, IL, USA.
Kate ElkingtonDepartment of Psychiatry, Vagelos College of Physicians and Scientists, New York State Psychiatric Institute, Columbia University, New York, NY, USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Technical Assistance CoreU2CDA050097 · NIDA · GEORGE MASON UNIVERSITY · PI Todd David Molfenter, Jessica Hulsey Nickel · 2019 to 2026
$37.0M
Reducing Opioid Mortality in Illinois (ROMI)UG1DA050066 · NIDA · UNIVERSITY OF CHICAGO · PI PHO, MAI TUYET, POLLACK, HAROLD ALEXANDER · 2019 to 2023
$15.5M
Using Implementation Interventions and Peer Recovery Support to Improve Opioid Treatment Outcomes in Community SupervisionU01DA050442 · NIDA · BROWN UNIVERSITY · PI BRINKLEY-RUBINSTEIN, LAUREN, MARTIN, ROSEMARIE A · 2019 to 2024
$12.6M
Long-acting naltrexone for pre-release prisoners: A randomized trial of mobile treatmentUG1DA050077 · NIDA · FRIENDS RESEARCH INSTITUTE, INC. · PI BLUE, THOMAS, GORDON, MICHAEL SCOTT · 2019 to 2023
$11.6M
Massachusetts Justice Cooperative Opioid Innovation Network (JCOIN) Research CenterUG1DA050067 · NIDA · UNIVERSITY OF MASSACHUSETTS AMHERST · PI EVANS, ELIZABETH A., FRIEDMANN, PETER D · 2019 to 2023
$10.5M
Justice Community Opioid Innovation Network (JCOIN): TCU Clinical Research CenterUG1DA050074 · NIDA · TEXAS CHRISTIAN UNIVERSITY · PI KNIGHT, DANICA K, KNIGHT, KEVIN · 2019 to 2023
$10.1M
Leveraging Social Networks to Increase COVID-19 Testing Uptake: A Comparison of Credible Messenger and Chain Referral Recruitment ApproachesUG1DA050071 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI ELKINGTON, KATHERINE S, NUNES, EDWARD V. · 2019 to 2023
$9.5M
Improving Retention across the OUD Service Cascade upon Re-entry from Jail using Recovery Management CheckupsUG1DA050065 · NIDA · CHESTNUT HEALTH SYSTEMS, INC. · PI DENNIS, MICHAEL L., GRELLA, CHRISTINE E · 2019 to 2023
$9.3M
Kentucky Women's Justice Community Opioid Innovation Network (WJCOIN)UG1DA050069 · NIDA · UNIVERSITY OF KENTUCKY · PI STATON, MICHELE · 2019 to 2023
$8.8M
Alliance to Disseminate Addiction Prevention and Treatment (ADAPT): A Statewide Learning Health System to Reduce Substance Use among Justice-Involved Youth in Rural Communities.UG1DA050070 · NIDA · INDIANA UNIVERSITY INDIANAPOLIS · PI AALSMA, MATTHEW · 2019 to 2023
$5.7M
HEAL Accelerator: Leveraging Partnerships and Targeted Dissemination to Advance UptakeOT2OD034479 · OD · GEORGE MASON UNIVERSITY · PI TAXMAN, FAYE S · 2022 to 2023
$5.6M
NCATS NIH HHS UL1 TR001863NIDA NIH HHS U01 DA050442NIDA NIH HHS U2C DA050097NIDA NIH HHS UG1 DA050065NIDA NIH HHS UG1 DA050066NIDA NIH HHS UG1 DA050067NIDA NIH HHS UG1 DA050069NIDA NIH HHS UG1 DA050070NIDA NIH HHS UG1 DA050071NIDA NIH HHS UG1 DA050074NIDA NIH HHS UG1 DA050077NIH HHS OT2 OD034479
6 · The paper itself

Abstract

Background: The outcomes of planned implementation efforts have been mixed, with some applications failing to achieve the desired change or impact. While reasons for mixed findings in implementation research are multifaceted (e.g., Damschroder et al., 2009, 2022), how the implementation strategy (IS) was deployed (i.e., integrity) and its impact on the implementation outcomes of evidence-based innovations (EBIs) is under-studied and warrants further clarification. Method: This article builds on the IS fidelity and mechanisms of change literature to create the Implementation Strategy Integrity Framework (ISIF). The ISIF was developed by a set of implementation science researchers in the Justice Community Opioid Innovation Network seeking to document the role of implementation strategies in influencing EBI outcomes. Results: The authors identified four areas of documentation and measurement to examine the role of IS integrity on EBI outcomes. (a) Implementation Strategy Rigor (i.e., adherence, dose, and quality) requires those implementing the strategy/strategies to specify them, document adherence to the planned strategies, quality of execution, and any adaptations made. (b) Target User Responsiveness documents the extent and quality of targeted users' participation in IS activities and how well the target users perform their roles in conducting actions intended by the implementation strategies. (c) Target Mechanism Activation notes to what degree the implementation strategies achieved the intended impact(s) on targeted factors that facilitate EBI use. Finally, (d) these three areas are combined with selected Inner and Outer Context variables to explain IS integrity's potential moderating and mediating effects on EBI outcomes. Conclusions: A framework that can define the integrity of an IS and allow for its subsequent use as an explanatory variable in EBI outcomes is necessary for better elucidating mechanisms of action. The ISIF offers a structured approach to operationalize, measure, and evaluate the application and related impacts of implementation strategies.

Indexed as

fidelityimplementation fidelityimplementation strategy fidelityIntegrity

Identifiers

PMID39650595
PMCPMC11622300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.